Kidney RSS News Feeds

Nephrology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Heerspink HJL et al. - This trial will be the first clinical test of the hypothesis that paricalcitol possesses pleiotropic effects and can modulate albuminuria in the setting of ACEI and/or ARB therapy.

Related Articles

Kidney Volume and Albuminuria as Markers of Birth Weight-Blood Pressure Relationship in Essential Hypertension
Kidney and Blood Pressure Research, 11/20/09    Relevance Score: 83%

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
Cardiovascular Diabetology, 11/24/09    Relevance Score: 80%

Is Cystatin C a Useful Marker in the Detection of Diabetic Kidney Disease
Nephron: Clinical Practice, 11/03/09    Relevance Score: 80%

Prehypertension: is it relevant for nephrologists
Kidney International, 11/19/09    Relevance Score: 77%

Today in Chronic Dz/Renal Failure...keeping you current

Susceptibility genes in common complex kidney disease
Current Opinion in Nephrology and Hypertension, 12/17/09

Renal homeostasis and tubuloglomerular feedback
Current Opinion in Nephrology and Hypertension, 12/17/09

The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease
Current Opinion in Nephrology and Hypertension, 12/17/09

Today in Radiology/Diagnostics...keeping you current

Increased Urinary Angiotensinogen Is Precedent to Increased Urinary Albumin in Patients With Type 1 Diabetes
The American Journal of the Medical Sciences, 12/17/09

Biological variation of cystatin C and creatinine
Scandinavian Journal of Clinical and Laboratory Investigation, 12/17/09

Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis
Arthritis Research & Therapy, 12/16/09